Super time and space transaction, I exchanged half a bottle of water for an aircraft carrier

""Alas!"

This time the secretary was a little surprised. Oris did not lose his temper. After sighing, he sat back in his chair very decadently.

However, the secretary also found that the spirit in President Oris's eyes had disappeared without a trace. Loser.

The secretary saw only the shadow of a loser in Oris.

The secretary could not bear to touch Oris's wound again, so she secretly left the office.

After returning to her seat, the secretary also secretly opened a resume.

This resume was not someone else's, but her own.

She had a premonition that Luo Hua seemed to be coming to an end.

Especially Luo Hua's Longguo branch, with the launch of this batch of new drugs from Ali Pharmaceuticals, it will definitely squeeze Luo Hua's living space in Longguo again.

After all, Ali Pharmaceuticals' drugs are newer, have fewer side effects, and are more effective. Well, the most important thing is that it is cheaper.

In addition, this is Longguo, the territory of Aili Pharmaceutical.

What can Luohua use to compete with Aili Pharmaceutical?

Use fists?

It seems impossible.

So the secretary is not optimistic about the future of Luohua Longguo Branch.

Closing down is only a matter of time.

If a man does not work for himself, he will be punished by heaven and earth.

It seems to be human nature for the secretary to find a better way out for himself in advance.

The same scene, in fact, not only appeared in Luohua Longguo Branch, but also in the Longguo branches of other world-renowned pharmaceutical companies.

For example, Johnson & Johnson, their chronic myeloid leukemia drug ibrutinib, has also been deeply affected.

Johnson & Johnson's ibrutinib is actually the latest new drug developed.

In terms of efficacy, it is actually comparable to Aili Pharmaceutical's Bailiwei.

But at this price. In terms of price, Ali Pharmaceuticals has crushed Johnson & Johnson.

The price of Ali Pharmaceuticals' Bailiwei is much cheaper than the old drug Gleevec, which has been used for more than ten years.

Not to mention compared with Johnson & Johnson's new drug.

With the significant improvement in efficacy and side effects, Johnson & Johnson has been selling this drug at a sky-high price.

The price of a 90-tablet version in Longguo is as high as 18,900.

And there is no worry about selling it, as there are many rich people in Longguo.

Originally, Johnson & Johnson wanted to make a fortune with Ibrutinib.

Who would have thought that Ali Pharmaceuticals' Bailiwei would emerge.

Ali Pharmaceuticals is simply unethical and cuts the price in half again and again.

The selling price is only one-fifth of that of Ibrutinib.

Therefore, since Bailiwei was launched on the market, the sales of Ibrutinib have plummeted.

And And because Johnson & Johnson has been unwilling to lower the price, the sales volume is even worse than that of Luohua's Gleevec.

In the end, Johnson & Johnson had to compromise.

Forced by the fact that the sales volume was almost zero, Johnson & Johnson could only lower its head and lower the price of Ibrutinib.

And it was only with the continuous efforts of the medical representatives that some sales were saved.

However, it is basically impossible to restore it to the previous state.

This is also the reason why Johnson & Johnson Longguo Branch attaches so much importance to the dynamics of Ali Pharmaceutical.

There is no way. Barton, the president of Johnson & Johnson Longguo Branch, has also asked someone to check the patent situation of Ali Pharmaceutical.

It would be better if he didn't check it, but he was shocked when he checked it.

Many of the drug patents registered by Ali Pharmaceutical overlap with drugs that Johnson & Johnson has already launched or is about to withdraw.

One white leevec has put Barton under a lot of pressure.

Ali Pharmaceutical still has so many drugs ready to be launched, which scares Barton half to death.

He lives a life of anxiety every day.

However, Barton can't do anything, and can only hope that the approval speed of these drugs of Ali Pharmaceutical will be slower.

Let him survive for a while longer. (To read exciting novels, go to Faloo Novel Network!)

But dreams are good, but reality is extremely cruel.

Barton thought that he had at least half a year left.

But who would have thought that only a month later, all the approvals for Ali Pharmaceuticals had been obtained and it could be put on the market.

Barton was extremely envious of the approval speed, but also felt powerless.

Barton knew that Johnson & Johnson's nightmare in Dragon Country was about to begin.[]

In the near future, Johnson & Johnson's living space in Dragon Country will be severely squeezed.

Whether it can survive in Dragon Country in the end is uncertain.

"Centralized procurement?"

When Li Shen was working hard to get the latest batch of drugs into the medical insurance catalog, he received an invitation from the Medical Insurance Administration to Aili Pharmaceutical to participate in the centralized procurement bidding.

Li Shen knew about centralized procurement.

Centralized procurement is the centralized bidding and procurement of drugs. It refers to the procurement method in which the National Medical Insurance Administration purchases the required drugs through centralized bidding and procurement of drugs.

This method can not only reduce the price of drugs on a large scale and reduce the burden on medical insurance funds.

It can also combat the unhealthy trends in the purchase and sale of medicines and reduce the cost of patients' medicines.

However, Aili Pharmaceutical is now supported by only Bailiwei.

And now Bailiwei can also create a lot of profits for the company.

If it participates in centralized procurement, the profit will definitely be greatly reduced.

In addition, Li Shen is just a manager now.

He is definitely not qualified to make such a major decision.

As for the big boss behind the scenes, Li Shen couldn't contact him even if he wanted to.

So he could only ask Zhao Yan for her opinion.

After calling Zhao Yan, Li Shen didn't waste any time and got straight to the point.

"Mr. Zhao, the Medical Insurance Administration has invited us to participate in this year's centralized procurement. I wonder if we would like to participate?"

"What is this centralized procurement?"

Zhao Yan has always had only a limited understanding of the medical industry, so she is a little unfamiliar with the term centralized procurement.

Li Shen also hurriedly explained to Zhao Yan:

"Centralized procurement is a centralized drug procurement method used by the Medical Insurance Administration......"

After explaining the centralized procurement, Li Shen was not finished.

He immediately explained the pros and cons of centralized procurement to Zhao Yan.

"Mr. Zhao, centralized procurement has both advantages and disadvantages. The advantage is that the volume will be larger. The disadvantage is that the profit will be very low."

""Okay, I got it. I'll ask the boss behind the scenes for his opinion and then I'll get back to you."

Zhao Yan understood the meaning of centralized procurement, but she didn't make a decision on her own. She knew very well that Zhang Yang was responsible for the success of Ali Pharmaceuticals, and most of the company's shares were in Zhang Yang's hands.

So Zhao Yan always believed that such a big decision still needed to be consulted with Zhang Yang.

"Okay, then I'll wait for Mr. Zhao's news."

Li Shen was not surprised that Zhao Yan needed to seek the opinions of the boss behind the scenes.

Isn't this normal?

This is a very important policy related to the future of the company, and the opinions of the major shareholders must be sought.

"Wait for my news!"

Zhao Yan didn't say anything more and hung up Li Shen's phone.

PS:Please give me flowers, evaluation votes, and a full approval.